The Patent Finder

Process for Obtaining Botulinum Neurotoxin

Allergan, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 11 of these applications claim priority to application 12/502,181, filed Jul 13, 2009. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 8,927,229Process and System for Obtaining Botulinum Neurotoxin
In force
 · High confidence
Allergan, Inc.In force
High confidence
US 9,719,076Process and System for Obtaining Botulinum Neurotoxin
In force
 · High confidence
Allergan, Inc.In force
High confidence
US 10,465,178Process and System for Obtaining Botulinum Neurotoxin
In force
 · Medium confidence
Allergan, Inc.In force
Medium confidence
US 11,124,786Process and System for Obtaining Botulinum Neurotoxin
In force
 · High confidence
Allergan, Inc.In force
High confidence
US 11,203,748Process and System for Obtaining Botulinum Neurotoxin
In force
 · High confidence
Allergan, Inc.In force
High confidence
US 11,326,155Process and System for Obtaining Botulinum Neurotoxin
In force
 · High confidence
Allergan, Inc.In force
High confidence
US 11,518,986Process and System for Obtaining Botulinum Neurotoxin
In force
 · High confidence
Allergan, Inc.In force
High confidence
US 11,525,130Process and System for Obtaining Botulinum Neurotoxin
In force
 · High confidence
Allergan, Inc.In force
High confidence
US 11,530,400Process and System for Obtaining Botulinum Neurotoxin
In force
 · High confidence
Allergan, Inc.In force
High confidence
US 12,241,098Process and System for Obtaining Botulinum Neurotoxin
In force
 · High confidence
Allergan, Inc.In force
High confidence
7 more patents in this group · Pro
10 of 17 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 17, including 1 expired.
Upgrade to Pro
12 of these are in force and held by Allergan, Inc..
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited